Urtica Dioica Fec D2 (D3) - Liquid 2 D Liquid is a Health Canada–registered human drug (DIN 02172232) held by Weleda AG Heilmittelbetriebe, containing Urtica Dioica. Health Canada lists its status as Cancelled Post Market (status date 06 Aug 2009). Nexara Health has matched 6 registrations of Urtica Dioica across 2 other regulated markets.
Health Canada registration
| DIN | 02172232 |
|---|---|
| Brand name | Urtica Dioica Fec D2 (D3) - Liquid |
| Active ingredient | Urtica Dioica |
| Strength | 2 D |
| Dosage form | Liquid |
| Route | Oral |
| Company | Weleda AG Heilmittelbetriebe |
| Status | Cancelled Post Market — 06 Aug 2009 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Urtica Dioica registered in other markets
6 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Itch care druppels | Kiwi Farm BV | Druppels voor oraal gebruik, oplossing | Uitsluitend apotheek of drogist | EU national register | |
| United States | Nettle | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Nettle | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Nettle | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Nettle | Greer Laboratories, Inc. | Solution | listed | FDA NDC | |
| United States | Nettle Pollen | Allermed Laboratories, Inc. | Injection | listed | FDA NDC |
See every manufacturer of Urtica Dioica worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Urtica Dioica Fec D2 (D3) - Liquid (DIN 02172232) marketed in Canada?
No. Health Canada lists DIN 02172232 as Cancelled Post Market as of 06 Aug 2009.
Who holds the Canadian licence for this product?
Weleda AG Heilmittelbetriebe is the company of record in the Health Canada Drug Product Database.
Is Urtica Dioica registered outside Canada?
Yes — Nexara Health has matched 6 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02172232, status date 2009-08-06; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02172232, status date 2009-08-06; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02172232, status date 2009-08-06; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.